Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

First combination anti-HIV drug approved in U.S.

Sep. 30, 1997

Filgrastim effects on lymphocytes in HIV infection

Sep. 26, 1997

Broad-spectrum chemokine antagonist blocks HIV cell entry

Sep. 26, 1997

AIDS dementia reversed by highly active antiretroviral therapy

Sep. 25, 1997

Short-term efficacy and safety of T-20 in HIV infection

Sep. 25, 1997

Oxandrolone + glutamine for HIV-associated wasting

Sep. 25, 1997

Columbia Laboratories issued U.S. patent for drug delivery technology

Sep. 23, 1997

Phase I results with HGP-30 AIDS vaccine reported

Sep. 22, 1997

Efavirenz/indinavir combination shows efficacy in phase II

Sep. 18, 1997

GEM-92 enters clinical trials for AIDS

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...